Literature DB >> 16226288

Apparent elimination of EIAV ancestral species in a long-term inapparent carrier.

Jodi K Craigo1, Timothy J Sturgeon, Sheila J Cook, Charles J Issel, Caroline Leroux, Ronald C Montelaro.   

Abstract

Equine infectious anemia virus (EIAV) envelope variation produces newly dominant quasispecies with each sequential disease cycle; new populations arise, and previous plasma quasispecies, including the original inoculum, become undetectable. The question remains whether these ancestral variants exist in tissue reservoirs or if the immune system eliminates quasispecies from persistent infections. To examine this, an EIAV long-term inapparent carrier was immune suppressed with dexamethasone. Immune suppression resulted in increased plasma viral loads by approximately 10(4) fold. Characterization of pre- and post-immune suppression populations demonstrated continual envelope evolution and revealed novel quasispecies distinct from defined populations from previous disease stages. Analysis of the tissue and plasma populations post-immune suppression indicated the original infectious inoculum and early populations were undetectable. Therefore, the host immune system apparently eliminated a diverse array of antigenic variants, but viral persistence was maintained by relentless evolution of new envelope populations from tissue reservoirs in response to ongoing immune pressures.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16226288     DOI: 10.1016/j.virol.2005.09.006

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Envelope variation as a primary determinant of lentiviral vaccine efficacy.

Authors:  Jodi K Craigo; Baoshan Zhang; Shannon Barnes; Tara L Tagmyer; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-10       Impact factor: 11.205

2.  Development of a high throughput, semi-automated, infectious center cell-based ELISA for equine infectious anemia virus.

Authors:  Jodi K Craigo; Corin Ezzelarab; Ronald C Montelaro
Journal:  J Virol Methods       Date:  2012-07-20       Impact factor: 2.014

3.  Unique evolution characteristics of the envelope protein of EIAV(LN₄₀), a virulent strain of equine infectious anemia virus.

Authors:  Xuefeng Wang; Shuai Wang; Yuezhi Lin; Chenggang Jiang; Jian Ma; Liping Zhao; Xiaoling Lv; Fenglong Wang; Rongxian Shen; Jianhua Zhou
Journal:  Virus Genes       Date:  2011-01-08       Impact factor: 2.332

4.  Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease.

Authors:  Jodi K Craigo; Shannon Barnes; Sheila J Cook; Charles J Issel; Ronald C Montelaro
Journal:  Vaccine       Date:  2010-10-16       Impact factor: 3.641

5.  Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition.

Authors:  Tara L Tagmyer; Jodi K Craigo; Sheila J Cook; Deborah L Even; Charles J Issel; Ronald C Montelaro
Journal:  J Virol       Date:  2008-01-30       Impact factor: 5.103

Review 6.  Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity.

Authors:  Jodi K Craigo; Ronald C Montelaro
Journal:  Viruses       Date:  2013-12-02       Impact factor: 5.048

7.  Protective efficacy of centralized and polyvalent envelope immunogens in an attenuated equine lentivirus vaccine.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Chong Liu; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS Pathog       Date:  2015-01-08       Impact factor: 6.823

8.  Surveillance of the equine infectious anemia virus in Eastern and Central Saudi Arabia during 2014-2016.

Authors:  Abdulmohsen Abdullah Alnaeem; Maged Gomaa Hemida
Journal:  Vet World       Date:  2019-05-29

9.  An EIAV field isolate reveals much higher levels of subtype variability than currently reported for the equine lentivirus family.

Authors:  Jodi K Craigo; Shannon Barnes; Baoshan Zhang; Sheila J Cook; Laryssa Howe; Charles J Issel; Ronald C Montelaro
Journal:  Retrovirology       Date:  2009-10-20       Impact factor: 4.602

10.  Envelope determinants of equine lentiviral vaccine protection.

Authors:  Jodi K Craigo; Corin Ezzelarab; Sheila J Cook; Liu Chong; David Horohov; Charles J Issel; Ronald C Montelaro
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.